Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ImmunoPrecise Antibodies (IPA)
NASDAQ:IPA
RESEARCH TOOLSreports
ImmunoPrecise Antibodies (IPA) Stock Price & Analysis
116 Followers
IPA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.94 - $4.22
Previous Close$1.22
Volume127.94K
Average Volume (3M)607.80K
Market Cap
$32.10M
Enterprise Value$38.08M
Total Cash (Recent Filing)C$6.20M
Total Debt (Recent Filing)C$14.39M
Price to Earnings (P/E)-2.9
Beta0.93
Next Earnings
Jul 25, 2024EPS Estimate
-$0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.42
Shares Outstanding25,050,260
10 Day Avg. Volume78,927
30 Day Avg. Volume607,802
Standard Deviation0.24
R-Squared0.00536
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)12.55
Price to Sales (P/S)5.44
Price to Cash Flow (P/CF)-15.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$9.00Price Target Upside653.77% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
ImmunoPrecise Antibodies News
PremiumCompany Announcements
IPA and InterSystems Partner for AI-Driven Healthcare
PremiumCompany Announcements
IPA and InterSystems Forge AI Healthcare Breakthrough
PremiumCompany Announcements
IPA Boosts AI Drug Discovery with Strategic Acquisition
PremiumCompany Announcements
IPA Enhances Drug Discovery with Carterra LSA
PremiumCompany Announcements
IPA Continues Growth Streak, Slashes Cash BurnOwnership Overview
Currently, No data available
---
IPA FAQ
What was ImmunoPrecise Antibodies’s price range in the past 12 months?
ImmunoPrecise Antibodies lowest stock price was $0.94 and its highest was $4.22 in the past 12 months.
What is ImmunoPrecise Antibodies’s market cap?
Currently, no data Available
When is ImmunoPrecise Antibodies’s upcoming earnings report date?
ImmunoPrecise Antibodies’s upcoming earnings report date is Jul 25, 2024 which is in 90 days.
How were ImmunoPrecise Antibodies’s earnings last quarter?
ImmunoPrecise Antibodies released its earnings results on Mar 14, 2024. The company reported -$0.08 earnings per share for the quarter, missing the consensus estimate of -$0.073 by -$0.007.
Is ImmunoPrecise Antibodies overvalued?
According to Wall Street analysts ImmunoPrecise Antibodies’s price is currently Undervalued.
Does ImmunoPrecise Antibodies pay dividends?
ImmunoPrecise Antibodies does not currently pay dividends.
What is ImmunoPrecise Antibodies’s EPS estimate?
ImmunoPrecise Antibodies’s EPS estimate is -$0.08.
How many shares outstanding does ImmunoPrecise Antibodies have?
ImmunoPrecise Antibodies has 26,315,260 shares outstanding.
What happened to ImmunoPrecise Antibodies’s price movement after its last earnings report?
ImmunoPrecise Antibodies reported an EPS of -$0.08 in its last earnings report, missing expectations of -$0.073. Following the earnings report the stock price went down -2.454%.
Which hedge fund is a major shareholder of ImmunoPrecise Antibodies?
Currently, no hedge funds are holding shares in IPA
---
ImmunoPrecise Antibodies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.00 (653.77% Upside)
$9.00 (653.77% Upside)
Insider Transactions
Bought Shares
Worth $60.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 9.3%
Last 30 Days ▼ 9.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-59.86%
12-Months-Change
Fundamentals
Return on Equity
-25.43%
Trailing 12-Months
Asset Growth
-4.67%
Trailing 12-Months
Company Description
ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd. engages in the provision of integrated antibody solutions. It services include human monoclonals, hybridoma development, rabbit monoclonals, b-cell select, phage display, cryostorage, hybridoma sequencing, antibody generation, anti-body purification, polyclonal production, and peptide production. The company was founded by Robert Beecroft in 1989 and is headquartered in Victoria, Canada.
---
IPA Earnings Call
Q3 2024
0:00 / 0:00
---
IPA Stock 12 Months Forecast
Average Price Target
$9.00
▲(653.77% Upside)
Technical Analysis
Best Analysts Covering IPA
1 Year
1 Year Success Rate
0/6 ratings generated profit
1 Year Average Return
-40.32%
reiterated a buy rating last month
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -40.32% per trade.
---